Cart
sales@molnova.com
Dyngo-4a
CAS No. 1256493-34-1
Dyngo-4a ( Dyngo-49; Dyngo 49;Hydroxy Dynasore )
Catalog No. M17909 CAS No. 1256493-34-1
Dyngo-4a , a effective dynamin inhibitor, inhibits withDynI (brain), DynI (rec), and DynII (rec) of IC50 of 0.38 μM, 1.1 μM, and 2.3 μM, respectively.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 41 | In Stock |
|
| 10MG | 68 | In Stock |
|
| 25MG | 125 | In Stock |
|
| 50MG | 210 | In Stock |
|
| 100MG | 312 | In Stock |
|
| 200MG | 464 | In Stock |
|
| 500MG | 743 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDyngo-4a
-
NoteResearch use only, not for human use.
-
Brief DescriptionDyngo-4a , a effective dynamin inhibitor, inhibits withDynI (brain), DynI (rec), and DynII (rec) of IC50 of 0.38 μM, 1.1 μM, and 2.3 μM, respectively.
-
DescriptionDyngo-49 is a dynamin inhibitor.
-
SynonymsDyngo-49; Dyngo 49;Hydroxy Dynasore
-
PathwayOthers
-
TargetOther Targets
-
RecptorDynI (brain); DynI (rec); DynII (rec)
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number1256493-34-1
-
Formula Weight338.31
-
Molecular FormulaC18H14N2O5
-
Purity98%
-
Solubility——
-
SMILESc1c(c(cc2ccccc12)O)C(=O)NN=Cc1c(cc(c(c1)O)O)O
-
Chemical Name3-Hydroxynaphthalene-2-carboxylic acid 2-[(2,4,5-trihydroxyphenyl)methylene]hydrazide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Harper CB., Targeting membrane trafficking in infection prophylaxis: dynamin inhibitors. Trends Cell Biol. 2013 Feb;23(2):90-101.
molnova catalog
related products
-
LW6
LW6 is a novel HIF-1 inhibitor.
-
Asp-Asp-Asp-Asp-Asp
Asp-Asp-Asp-Asp-Asp is a peptide consists of 5 Asp.
-
Eledoisin Related Pe...
Eledoisin Related Peptide(2TFA)is a tachykinin receptor ligand.Substance P and eledoisin-related peptide had excitatory effects on respiratory neurones and reflex interneurones, but compared with glutamate-induced effects the excitation was slower in onset and more prolonged in after-discharge.
